StimCardio closes oversubscribed $30 million Series A financing led by Metis Medtech to advance their wearable therapeutic for atrial fibrillation.
Amount Raised
$30 Million
Round Type
Series A
Los AngelesBiotechnologyHealth CareMedicalMedical DeviceTherapeuticsInvestors
Description
StimCardio, a clinical-stage medical device company, has closed an oversubscribed $30 million Series A financing. The funding, led by John Slump's family office, Metis Medtech, will support a pivotal trial for their investigational therapy Rhyvive™. This investment also aids in the preparation for a De Novo submission to the FDA. The company aims to innovate cardiac treatment beyond conventional methods.
Quick answer
StimCardio raised $30 Million in a Series A round, dated October 29, 2026. Investors: Catalyst Health Ventures and Metis Medtech. StimCardio is based in Los Angeles, California, United States.
- How much did StimCardio raise?
- StimCardio raised $30 Million in a Series A round on October 29, 2026.
- Who invested in StimCardio?
- Catalyst Health Ventures and Metis Medtech are named as investors in this round.
- What does StimCardio do?
- StimCardio is a clinical-stage medical device company developing non-invasive wearable therapeutics for atrial fibrillation (AF).
- Where is StimCardio based and how big is it?
- StimCardio is based in Los Angeles, California, United States. Fundz records about 2 employees.
- Who are the decision-makers at StimCardio?
- Fundz holds 2 contacts at StimCardio, including the CEO. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Medical and Medical Device around the same time
Companies in the same sectors as StimCardio that raised within 45 days of this round, from Fundz verified event records.
- Aqua Medical raised an undisclosed amount (Series B) on September 23, 2026.
- Skribe Medical raised $1.6M (Pre-Seed) on November 12, 2026.
- Orakl Oncology raised $34M (Series A) on November 12, 2026.
- EnVision Endoscopy raised $12M (Series A) on November 10, 2026.
- Alethio raised $90M (Series A) on November 5, 2026.
- Laza Medical raised $160M (Series B) on November 4, 2026.
Who to call at StimCardio, and when
A new round usually means StimCardio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day StimCardio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at StimCardio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at StimCardio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment StimCardio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansStimCardio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.